BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 2, Issue 3 , Pages 163-167 , July 2009

The effect of daily prefrontal repetitive transcranial magnetic stimulation over several weeks on resting motor threshold

  • Paul Zarkowski, MD

      Affiliations

    • University of Washington, Seattle, Washington
    • Corresponding Author InformationCorrespondence: Dr. Paul Zarkowski, 325 Ninth Ave, Box 359895, Seattle WA, 98104-2499.
    • ,
  • Rita Navarro, MD

      Affiliations

    • University of Washington, Seattle, Washington
    • ,
  • Martina Pavlicova, PhD

      Affiliations

    • Columbia University, New York, New York
    • ,
  • Mark S. George, MD

      Affiliations

    • Brain Stimulation Laboratory, Medical University of South Carolina, Charleston, South Carolina
    • ,
  • David Avery, MD

      Affiliations

    • University of Washington, Seattle, Washington

Received 24 July 2008 ,Revised 21 January 2009 ,Accepted 4 February 2009.

References 

  1. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208–1216
  2. Avery DH, Holtzheimer PE, Fawaz W, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry. 2006;59(2):187–194
  3. George MS, Wassermann EM, Kimbrell TA, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry. 1997;154(12):1752–1756
  4. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108(1):1–16
  5. Poulet E, Auriacombe M, Tignol J. [Seizure threshold and ECT. Importance for good clinical practice of ECT. A review of literature]. Encephale. 2003;29(2):99–107
  6. Amiaz R, Stein O, Schreiber S, Danon PN, Dolberg OT, Grunhaus L. Magnetic and seizure thresholds before and after six electroconvulsive treatments. J ECT. 2001;17(3):195–197
  7. Fleischmann A, Prolov K, Abarbanel J, Belmaker RH. The effect of transcranial magnetic stimulation of rat brain on behavioral models of depression. Brain Res. 1995;699(1):130–132
  8. Belmaker RH, Grisaru N. Magnetic stimulation of the brain in animal depression models responsive to ECS. J ECT. 1998;14(3):194–205
  9. Lisanby SH, Belmaker RH. Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS). Depress Anxiety. 2000;12(3):178–187
  10. Triggs WJ, McCoy KJ, Greer R, et al. Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold. Biol Psychiatry. 1999;45(11):1440–1446
  11. Bajbouj M, Brakemeier EL, Schubert F, et al. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex and cortical excitability in patients with major depressive disorder. Exp Neurol. 2005;196(2):332–338
  12. Dolberg OT, Dannon PN, Schreiber S, Grunhaus L. Magnetic motor threshold and response to TMS in major depressive disorder. Acta Psychiatr Scand. 2002;106(3):220–223
  13. Cantello R, Rossi S, Varrasi C, et al. Slow repetitive TMS for drug-resistant epilepsy: clinical and EEG findings of a placebo-controlled trial. Epilepsia. 2007;48(2):366–374
  14. Palmieri MG, Iani C, Scalise A, et al. The effect of benzodiazepines and flumazenil on motor cortical excitability in the human brain. Brain Res. 1999;815(2):192–199
  15. Kimiskidis VK, Papagiannopoulos S, Kazis DA, et al. Lorazepam-induced effects on silent period and corticomotor excitability. Exp Brain Res. 2006;173(4):603–611
  16. Mohammadi B, Krampfl K, Petri S, et al. Selective and nonselective benzodiazepine agonists have different effects on motor cortex excitability. Muscle Nerve. 2006;33(6):778–784
  17. Paulus W, Classen J, Cohen L, et al. State of the art: pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation. Brain Stimulation. 2008;1:151–163
  18. Manganotti P, Bongiovanni LG, Fuggetta G, Zanette G, Fiaschi A. Effects of sleep deprivation on cortical excitability in patients affected by juvenile myoclonic epilepsy: a combined transcranial magnetic stimulation and EEG study. J Neurol Neurosurg Psychiatry. 2006;77(1):56–60
  19. Ziemann U, Lonnecker S, Paulus W. Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study. Brain. 1995;118(Pt 6):1437–1446
  20. Hattemer K, Knake S, Reis J, et al. Excitability of the motor cortex during ovulatory and anovulatory cycles: a transcranial magnetic stimulation study. Clin Endocrinol (Oxf). 2007;66(3):387–393

 The OPT-TMS study is supported by grants from the NIMH (5 R01 MH069887-04).

 Dr Avery currently receives funding from 5 R01 MH069887-04 and R21 AR053963-01. He has been a paid consultant to Northstar Neuroscience, Neuronetics, Inc, and Performance Plus. Dr Avery has received honorariums for speaking engagements from Eli Lilly and Takeda. For the past decade, his entire yearly compensation from all companies and speaking engagements is less than 5% of his university salary.

 Dr George currently receives funding from 5 R01 MH069887-04, 5 P20 DA022658-02, 1 R21 MH078046-01. He is a paid consultant to several device manufacturers, including Neuropace (DBS) and Cyberonics (VNS). He is an unpaid consultant to several TMS manufacturers (Neuronetics, Brainsway), and served as head of the DSMB for Aspect Medical. For the past decade, his entire yearly compensation from all manufacturers and speaking engagements is less than 20% of his university salary. He is the editor-in-chief of a new journal published by Elsevier, entitled Brain Stimulation and has written several books in this area. MUSC holds several patents in his name involving brain stimulation and imaging, one using fMRI (not EEG) to determine the best dose of VNS for a patient.

 Drs Zarkowski, Navarro, and Pavlicova have received funding from 5 R01 MH069887-04.

PII: S1935-861X(09)00008-4

doi: 10.1016/j.brs.2009.02.001

BRAIN STIMULATION: Basic, Translational, and Clinical Research in Neuromodulation
Volume 2, Issue 3 , Pages 163-167 , July 2009

Article Tools

* Image Usage & Resolution